Probiotics containing Lactobacillus are promising candidates for cisplatin-induced cardiotoxicity. [PDF]
Alhilal M +7 more
europepmc +1 more source
Determining Preclinical Safety of Aclarubicin in Pediatric Malignancies
ABSTRACT Background Anthracyclines are among the most effective chemotherapeutic agents used to treat pediatric malignancies. However, their clinical use is limited by dose‐dependent toxicities, particularly cardiotoxicity and secondary malignancies.
Darleen S. Tu +15 more
wiley +1 more source
Prospective multicenter evaluation of 18F-FDG PET/CT and strain for early cardiotoxicity detection in lymphoma patients. [PDF]
Becker MMC +9 more
europepmc +1 more source
Dexrazoxane Cardioprotection in pediatric ALL: a historical control cohort study. [PDF]
Liu L +11 more
europepmc +1 more source
Cardiac digital twins: Modelling the arrhythmic substrate of chemotherapy
The Journal of Physiology, EarlyView.
Radomir Chabiniok, Vlad G. Zaha
wiley +1 more source
ABSTRACT Loperamide is a widely used nonprescription peripherally acting opioid indicated for diarrhea. Loperamide undergoes extensive first‐pass metabolism, primarily by cytochrome (CYP) 3A and CYP2C8, with minor contributions from CYP2B6 and CYP2D6, and intestinal efflux by P‐glycoprotein (P‐gp).
Zhu Zhou +6 more
wiley +1 more source
A serum biomarker panel for early detection of treatment-related cardiotoxicity in early HER2-positive breast cancer patients. [PDF]
Ahmed NA +5 more
europepmc +1 more source
Cardiooncology. Basic principles of prevention and treatment of cardiotoxicity in cancer patients
E. V. Plokhova, David Doundoua
openalex +1 more source
Transient 7‐hour coma following a sacrococcygeal epidural with ropivacaine in a cat
Abstract A 2‐year‐old cat was anaesthetised for pelvic fracture repair. Premedication included methadone 0.2 mg/kg and medetomidine 5 µg/kg intravenously (IV). Anaesthesia was induced with ketamine 2 mg/kg and propofol 1 mg/kg IV and maintained with isoflurane.
Morgane Gavet +4 more
wiley +1 more source
GLP-1 Receptor Agonist Exenatide Protects Against Doxorubicin-Induced Cardiotoxicity Through the SIRT1 Pathway: An Electrocardiographic, 99mTc-PYP Scintigraphic, and Biochemical Study. [PDF]
Salmanoglu M +4 more
europepmc +1 more source

